How Advanced Are Hong Kong Ovarian Reserve Assessment Technologies - Interpretation of AMH Testing and Antral Follicle Count Methods
Hong Kong ovarian reserve assessment technologies, centered on automated chemiluminescence AMH testing and transvaginal ultrasound antral follicle count, are not restricted by the menstrual cycle and provide precise results. This article provides a detailed interpretation of assessment methods, indicator significance, and clinical applications across different age groups from a reproductive medicine perspective, helping patients understand the relationship between ovarian reserve function and fertility decisions.
========= Article Header =========
Hong Kong ovarian reserve assessment technologies are centered on serum AMH (anti-Müllerian hormone) automated chemiluminescence testing and transvaginal ultrasound antral follicle count (AFC). Both indicators are not strictly limited by the menstrual cycle, allowing for flexible scheduling of examinations. AMH reflects the number of remaining follicles in the ovaries, while AFC directly observes the development of basal antral follicles. The accuracy of combined assessment is higher than using a single indicator. Reproductive medicine centers in Hong Kong commonly use fully automated platforms such as Roche Cobas and Siemens Immulite, achieving detection precision that meets international standards. The reference ranges for AMH vary significantly among women of different ages: the median value for those under 30 is approximately 3.0–5.0 ng/mL, while for those over 40, it is below 1.0 ng/mL. The assessment results directly guide the selection of ovulation induction protocols and drug dosage adjustments, making it a crucial step before entering assisted reproductive treatment.
In reproductive medicine outpatient clinics, we encounter patients who need ovulation induction protocols every day. Whether it is due to unsuccessful attempts at pregnancy for a year or planning for in vitro fertilization, the first step is always to answer the same question: What is the patient's ovarian reserve function? The answer to this question directly determines the starting dose of gonadotropins, the type of protocol (antagonist protocol, agonist protocol, or mild stimulation protocol), and the expected number of follicles that can be obtained. Hong Kong's ovarian reserve assessment technologies play a central role in this decision-making process.
A 35-year-old patient with an AMH of 1.2 ng/mL and a total antral follicle count of 6 in both ovaries will have a completely different ovulation induction protocol compared to a peer with an AMH of 3.8 ng/mL and an AFC of 16. The former may require a higher starting dose and might even need to consider adding growth hormone; the latter is suitable for a standard dose and requires vigilance against Ovarian Hyperstimulation Syndrome. Without an accurate assessment, subsequent treatment is like feeling an elephant blindfolded.
============================================================ Module A: Direct Answer to the Question ============================================================1. What Core Components Are Included in Hong Kong Ovarian Reserve Assessment Technologies?
The ovarian reserve assessment system used by reproductive medicine centers in Hong Kong is completely consistent with mainstream international standards, primarily including the following three core examinations:
- Serum AMH Testing (Anti-Müllerian Hormone) — Reflects the number of remaining follicles in the ovaries, is not affected by the menstrual cycle, and blood can be drawn at any time.
- Transvaginal Ultrasound Antral Follicle Count (AFC) — Observes the number of basal antral follicles (2–10 mm in diameter) in both ovaries via transvaginal ultrasound on days 2–4 of the menstrual cycle.
- Basal Endocrine Hormone Measurement (FSH, LH, E2, Inhibin B) — Blood draw in the early follicular phase to assist in judging ovarian reserve.
Among these, the AMH + AFC combined assessment is currently the most accurate combination for predicting ovarian response. All centers in Hong Kong with assisted reproductive technology qualifications routinely perform these two tests. Some centers also offer 3D ultrasound ovarian volume measurement as a supplementary reference.
============================================================ Module C: Doctor's Perspective ============================================================2. How Are These Assessment Technologies Viewed from a Clinical Perspective?
The value of AMH lies in its stability and forward-looking nature. Unlike FSH, it is not affected by menstrual cycle fluctuations. The coefficient of variation for AMH in the same patient tested at different times in the cycle is usually less than 15%. This allows us to complete the assessment at any time without waiting for menstruation.
The advantage of AFC lies in its intuitiveness. Transvaginal ultrasound allows direct visualization of the developing basal antral follicles in the ovaries, which are the reserves about to enter the growth trajectory. If the AFC is very low, even if the AMH is at a borderline value, one must be alert to poor ovarian response.
In actual decision-making, I rely more on the consistency between AMH and AFC. If both indicate normal reserve, the patient's response to ovulation induction drugs is usually good; if they are inconsistent, a comprehensive judgment needs to be made by combining factors such as age and history of ovarian surgery.
It must be clarified: No single test can perfectly predict egg quality. Ovarian reserve assessment primarily reflects the quantity of follicles, not the chromosomal normality rate of the eggs. The latter is closely related to age. This is why a young patient with low AMH, although the number of eggs retrieved may be few, often has a higher utilization rate per egg compared to an older patient with normal AMH.
============================================================ Module L: Interpretation of Test Indicators + Table ============================================================3. Interpretation of Core Indicators and Reference Ranges
Different testing platforms are used by reproductive medicine centers in Hong Kong, so reference ranges may vary slightly. The following are commonly used clinical reference values, all based on automated chemiluminescence immunoassay (CLIA/ECLIA):
| Indicator | Testing Method | Normal Range (Reproductive Age) | Clinical Significance |
|---|---|---|---|
| AMH | Automated Chemiluminescence Immunoassay | 1.5–6.8 ng/mL (under 30 years) 0.8–4.0 ng/mL (30–38 years) 0.3–1.8 ng/mL (38–42 years) |
Reflects ovarian reserve quantity, not affected by menstrual cycle |
| Antral Follicle Count (AFC) | Transvaginal Ultrasound (7–10 MHz) | ≥ 10 (total for both ovaries) | Direct observation of basal antral follicle number, tested in early follicular phase |
| Basal FSH | Chemiluminescence Immunoassay | < 10 IU/L | Elevation suggests decreased ovarian reserve, tested on days 2–4 of the cycle |
| Inhibin B | Enzyme-Linked Immunosorbent Assay | > 45 pg/mL | Positively correlated with AFC, reflects early follicular activity |
The AMH test kits used in Hong Kong are mainly the Roche Cobas e series and Siemens Immulite 2000. Both use a double-antibody sandwich method, with a detection limit as low as 0.01 ng/mL and high precision. Values from different platforms are not directly interchangeable, so continuous monitoring is recommended at the same center. Laboratories in Hong Kong participate in international external quality assessment schemes (e.g., UK NEQAS), ensuring the reliability of results.
4. Assessment Differences for Women of Different Ages
Ovarian reserve naturally declines with age, but the rate of decline varies individually. The following analysis focuses on assessment points for three typical age groups:
Under 30 Years
At this stage, the median AMH is typically 3.0–5.0 ng/mL, and the total AFC for both ovaries is 12–20. The purpose of assessment is mainly to rule out abnormally high AMH caused by Polycystic Ovary Syndrome (PCOS) or early ovarian insufficiency. If AMH is below 1.0 ng/mL, one should be alert to premature depletion of ovarian reserve, and further testing for chromosomes and autoimmune antibodies is recommended.
30–38 Years
This is the most clinically complex range. Some women experience an accelerated decline in AMH, yet their menstrual cycles remain regular. Reproductive doctors in Hong Kong focus on the annual rate of AMH decline. If AMH drops from 2.5 to 1.8 ng/mL within a year, even if the absolute value is still within the normal range, it suggests a relatively fast decline in reserve. A comprehensive judgment combining AFC and Inhibin B is recommended.
Over 38 Years
In this age group, the median AMH has dropped to around 1.0 ng/mL, and AFC is usually less than 8. The purpose of assessment is no longer to judge whether it is "normal," but to predict the response to ovulation induction and formulate an individualized protocol. For patients with AMH below 0.5 ng/mL, some centers in Hong Kong adopt mild stimulation or natural cycle protocols to reduce the cycle cancellation rate.
============================================================ Module G: Most Easily Overlooked Details ============================================================5. Most Easily Overlooked Details
In clinical work, the following three details are often overlooked by patients and even some doctors, but they have a direct impact on the accuracy of the assessment results:
- AMH testing is not limited by the menstrual cycle, but it is affected by oral contraceptives. Long-term use of combined oral contraceptives can lower AMH levels by approximately 20–30%, and it takes at least 3 months after discontinuation to return to baseline levels. If a patient is taking them, it should be clearly documented in the medical records.
- Inconsistent AFC counting standards. Different ultrasound doctors may have varying definitions of "antral follicle." Reproductive centers in Hong Kong typically use the 2–10 mm standard for counting and require separate counts for each ovary to avoid omissions. It is recommended to have follow-up scans at the same center and ideally by the same ultrasound doctor to reduce inter-operator variability.
- Interpretation of basal FSH requires consideration of E2 levels. If FSH is within the normal range but E2 is above 80 pg/mL, it may indicate that ovarian function has begun to decline. In this case, FSH might be suppressed by the high E2 and appear normal. Relying solely on FSH can easily lead to missed diagnosis.
6. Frequently Asked Questions
7. Practitioner's Observation: Clinical Characteristics of Ovarian Reserve Assessment in Hong Kong
In my years working in reproductive medicine in Hong Kong, I have observed several notable trends:
First, AMH testing is becoming increasingly popular. Five years ago, many patients did not know what AMH was. Now, almost all women who have been trying to conceive for more than 6 months actively request an AMH test. This shows that patient education has achieved tangible results.
Second, the standardization of AFC is improving. Ultrasound doctors in Hong Kong have all undergone specialized training in reproductive medicine, leading to a unified standard for antral follicle counting and reducing result variability between different centers. This is very important for continuous patient monitoring.
Third, age is overemphasized, while the AMH trend is underestimated. Many older patients think, "I'm older, so my ovarian function must be poor," and give up on assessment entirely. This is a misconception. In reality, about 15% of women aged 38 still have an AMH above 2.0 ng/mL, and the ovulation induction response of these patients is not significantly different from that of 30-year-old women. The purpose of assessment is to replace guesswork with data.
8. Special Situation Management
Extra attention to adjusting the assessment strategy is needed in the following three situations:
- Single Ovary or Post-Ovarian Surgery — AMH can still reflect the overall reserve, but AFC only targets the existing ovary. In this case, the weight of AMH should be higher than that of AFC. If post-surgery AMH is below 0.5 ng/mL, it is recommended to proceed to an assisted reproductive cycle as soon as possible.
- Polycystic Ovary Syndrome (PCOS) — AMH is usually significantly elevated (>5.0 ng/mL), and AFC > 20. The focus of assessment is not insufficient reserve, but preventing Ovarian Hyperstimulation Syndrome (OHSS). Centers in Hong Kong adopt low-dose step-up protocols with continuous monitoring.
- Ovarian Endometrioma (Chocolate Cyst) — Cysts can affect the accuracy of AFC, as some follicles may be compressed or encapsulated and not clearly visible on ultrasound. In this case, AMH has greater reference value. If AMH is significantly low, it is recommended to surgically treat the cyst first before reassessment.
Ovarian reserve assessment is an important reference for fertility decisions, but it should not be the sole basis for judgment. AMH and AFC reflect the number of follicles, but they cannot directly assess the chromosomal normality rate of eggs or embryo developmental potential. Some patients with normal AMH experience repeated implantation failure, which may be related to egg quality, endometrial receptivity, or immune factors.
Furthermore, there may be systematic biases in AMH test values between different laboratories. If cross-center comparison is needed, it is essential to confirm whether the testing platform and kit are the same. Reproductive centers in Hong Kong usually indicate the testing method and reference range in their reports, and patients should keep all original reports safely.
Any abnormal assessment results should be interpreted under the guidance of a reproductive doctor. It is not recommended to draw conclusions by comparing with online reference values. The doctor will develop an individualized plan based on a complete medical history, previous treatment responses, and partner factors.
9. Assessment Process and Time Schedule Reference
Completing a full ovarian reserve assessment in Hong Kong usually follows this process:
- AMH Blood Draw — Any time, no fasting required, no specific menstrual cycle day needed. Results are typically available in 2–3 working days.
- Transvaginal Ultrasound AFC — Recommended on days 2–4 of the menstrual cycle. If the cycle is irregular, blood can be drawn for hormones first, and then the ultrasound can be scheduled. Some centers can complete the blood draw and ultrasound on the same day.
- Basal Hormones (FSH, LH, E2) — Blood draw on the same day as AFC, usually on days 2–4 of the menstrual cycle.
- Comprehensive Report Interpretation — After all reports are available, the reproductive doctor conducts a comprehensive evaluation, typically requiring a 30–45 minute outpatient consultation.
The entire process, from scheduling to receiving the comprehensive interpretation, can be completed in as fast as 1 week. For patients with tight schedules, centers in Hong Kong usually offer one-stop appointment services, arranging the blood draw, ultrasound, and consultation within the same half-day.
============================================================ Supplement: Doctor's Advice ============================================================Women planning to undergo ovarian reserve assessment should pay attention to the following points:
- Stop taking oral contraceptives or other sex hormone medications 3 months before the test, unless otherwise instructed by your doctor.
- Do both AMH and AFC tests; do not only check one of them.
- Keep all original reports, including information on the testing platform and reference range.
- Do not be overly anxious about a single low AMH result; it is recommended to repeat the test after 3 months to confirm the trend.
- Assessment results should be interpreted in conjunction with age, weight, previous pregnancy history, surgical history, etc.
— This article was written by clinicians from the Reproductive Medicine Center. The content is for patient education reference only and does not serve as a basis for individual diagnosis or treatment. Please consult your attending physician for specific assessment plans.
0 comments